Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

FDA approves BTG's drug for cancer toxicity

January 18, 2012 — WASHINGTON (Reuters) - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.

China cancer village tests law against pollution

January 16, 2012 — XIAOXIN, China (Reuters) - Nothing in Wu Wenyong's rural childhood hinted he would end up on a hospital bed aged 15, battling two kinds of cancer.

Cancer drug gets stronger label warning

January 13, 2012 —

REFILE: Eighth retraction marks slide of lung cancer work

January 9, 2012 — NEW YORK (Reuters Health) - In a reminder of how much a once-heralded area of lung cancer research has crumbled, a former Duke oncologist and his colleagues issued their eighth study retraction late last week.